1. Home
  2. SRFM vs COYA Comparison

SRFM vs COYA Comparison

Compare SRFM & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surf Air Mobility Inc.

SRFM

Surf Air Mobility Inc.

N/A

Current Price

$1.16

Market Cap

110.4M

ML Signal

N/A

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

N/A

Current Price

$4.87

Market Cap

97.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SRFM
COYA
Founded
2011
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.4M
97.8M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
SRFM
COYA
Price
$1.16
$4.87
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$3.25
$15.80
AVG Volume (30 Days)
3.6M
161.5K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
45.69
N/A
EPS
N/A
N/A
Revenue
$106,557,000.00
$7,945,753.00
Revenue This Year
$25.90
N/A
Revenue Next Year
$20.72
$763.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
123.57
52 Week Low
$1.01
$3.71
52 Week High
$9.35
$7.75

Technical Indicators

Market Signals
Indicator
SRFM
COYA
Relative Strength Index (RSI) 46.06 56.35
Support Level $1.06 $4.50
Resistance Level $1.36 $5.18
Average True Range (ATR) 0.09 0.32
MACD -0.01 -0.00
Stochastic Oscillator 33.33 49.99

Price Performance

Historical Comparison
SRFM
COYA

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc is a regional air mobility platform operating commuter airlines in the United States and expanding an on-demand charter marketplace for passengers in the U.S. and globally. It is also focused on developing a proprietary aviation software, aircraft electrification powertrain technology and services to enable electrification across the regional air mobility sector. The company operates in a single reportable segment, Air Mobility. The Air Mobility segment derives revenue from operating scheduled commercial air service flights, which are sold to the public mainly on a per-seat basis; through subsidized EAS revenue awards from the Department of Transportation; and by operating on-demand flights for customers on an ad-hoc, by request basis.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: